Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter S Winter

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Science Signaling|December 25, 2014
Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A Martz, Kathleen A Ottina, Katherine R Singleton, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
The Journal of Clinical Investigation|December 2, 2014
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A Gerriets, Rigel J Kishton, Amanda G Nichols, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1Christopher F Bassil, Gray R Anderson, Benjamin Mayro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2019
Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancerBashar Hamza, Sheng Rong Ng, Sanjay M Prakadan, et al.
Nature Metabolism|August 19, 2024
Cancer tissue of origin constrains the growth and metabolism of metastasesSharanya Sivanand, Yetis Gultekin, Peter S Winter, et al.
Nature Communications|January 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridgeChristopher F Bassil, Kerry Dillon, Gray R Anderson, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nature|June 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn, et al.
Science Translational Medicine|December 16, 2016
PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGray R Anderson, Suzanne E Wardell, Merve Cakir, et al.
Science Signaling|December 25, 2014
Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A Martz, Kathleen A Ottina, Katherine R Singleton, et al.
Cell Reports|July 27, 2017
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor EvolutionGrace R Anderson, Peter S Winter, Kevin H Lin, et al.
Nature Biotechnology|October 7, 2024
Scalable, compressed phenotypic screening using pooled perturbationsNuo Liu, Walaa E Kattan, Benjamin E Mead, et al.
The Journal of Clinical Investigation|December 2, 2014
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A Gerriets, Rigel J Kishton, Amanda G Nichols, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1Christopher F Bassil, Gray R Anderson, Benjamin Mayro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2019
Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancerBashar Hamza, Sheng Rong Ng, Sanjay M Prakadan, et al.
Nature Metabolism|August 19, 2024
Cancer tissue of origin constrains the growth and metabolism of metastasesSharanya Sivanand, Yetis Gultekin, Peter S Winter, et al.
Nature Communications|January 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridgeChristopher F Bassil, Kerry Dillon, Gray R Anderson, et al.
Pageof 4